Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
20.00
-0.55 (-2.68%)
At close: Dec 5, 2025, 4:00 PM EST
19.02
-0.98 (-4.90%)
After-hours: Dec 5, 2025, 6:09 PM EST
Burning Rock Biotech Revenue
Burning Rock Biotech had revenue of 131.62M CNY in the quarter ending September 30, 2025, with 2.31% growth. This brings the company's revenue in the last twelve months to 539.28M, up 5.56% year-over-year. In the year 2024, Burning Rock Biotech had annual revenue of 515.82M, down -4.02%.
Revenue (ttm)
539.28M CNY
Revenue Growth
+5.56%
P/S Ratio
2.81
Revenue / Employee
800,111 CNY
Employees
674
Market Cap
215.33M USD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BNR News
- 5 days ago - Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025 - GlobeNewsWire
- 16 days ago - Burning Rock Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Burning Rock's OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer - GlobeNewsWire
- 3 months ago - Burning Rock Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Burning Rock Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 9 months ago - Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 1 year ago - Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewsWire
- 1 year ago - Burning Rock Reports Third Quarter 2024 Financial Results - GlobeNewsWire